Racecadotril for Acute Loose Stools
Racecadotril is an appropriate and effective treatment for acute watery diarrhea in stable patients without severe dehydration or invasive infection, used as an adjunct to oral rehydration therapy.
Clinical Appropriateness
Racecadotril is suitable for self-medication in acute diarrhea when the following criteria are met 1:
- Age over 12 years (though pediatric formulations exist for younger patients)
- Absence of warning signs:
- No dysentery (high fever >38.5°C and/or frank blood in stools)
- No severe vomiting that could cause rapid dehydration
- No obvious dehydration
- No severe systemic illness
The drug works by inhibiting neutral endopeptidase, allowing enkephalins to reduce intestinal water and electrolyte secretion without affecting gut motility 2. This mechanism differs fundamentally from loperamide, which slows intestinal transit.
Recommended Dosage
For adults: 100 mg three times daily (every 8 hours) 3, 4
For children: 1.5 mg/kg body weight orally every 8 hours 5, 6
Note: The provided FDA drug labels 7 incorrectly reference carvedilol (a beta-blocker) rather than racecadotril, so these should be disregarded for dosing information.
Evidence of Efficacy
Racecadotril demonstrates superior efficacy compared to placebo across multiple parameters 4:
- Reduces stool output by approximately 46-50% in the first 48 hours 5, 6
- Decreases duration of diarrhea significantly (median 28 hours vs 72 hours with placebo) 5
- Reduces number of diarrheal stools 3
- Decreases need for oral rehydration solution 5
When compared to loperamide, racecadotril shows similar efficacy but with important advantages 4, 8:
- Similar speed of symptom resolution
- Less rebound constipation (a critical quality-of-life consideration)
- Less abdominal discomfort
- Better tolerability profile overall
Safety Profile
Racecadotril has an excellent safety record with adverse event rates similar to placebo 4, 9. Most adverse events are mild and transient 5. The drug does not increase risk of constipation, unlike loperamide, making it preferable from a quality-of-life perspective 4, 8.
Clinical Context and Caveats
Important limitation: While older guidelines 1 recommend loperamide as the drug of choice for self-medication of acute diarrhea, this predates the extensive evidence base for racecadotril. More recent systematic reviews 4, 8 demonstrate racecadotril's superior tolerability profile, particularly regarding rebound constipation.
When to avoid racecadotril:
- Patients with dysentery or bloody stools (require medical evaluation and possible antibiotics)
- Severe dehydration (requires immediate rehydration, possibly intravenous)
- Patients requiring hospitalization with severe disease (octreotide may be more effective) 4
When to seek medical attention:
- No improvement within 48 hours
- Development of warning signs (fever, blood in stools, severe vomiting, dehydration)
- Worsening symptoms 1
Practical Implementation
Racecadotril should be used as adjunct therapy alongside adequate fluid intake 1, 5, 6. Patients should:
- Maintain fluid intake guided by thirst
- Use glucose-containing drinks or electrolyte-rich soups
- Eat small, light meals as tolerated
- Avoid fatty, spicy foods and caffeine
The drug can reduce healthcare costs by decreasing hospitalizations and need for parenteral rehydration 10, 2, making it both clinically and economically advantageous.